PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.8815
-0.0394 (-4.28%)
At close: Jan 9, 2026, 4:00 PM EST
0.9032
+0.0217 (2.46%)
After-hours: Jan 9, 2026, 7:35 PM EST
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.93 million as of January 9, 2026. Its market cap has decreased by -19.52% in one year.
Market Cap
8.93M
Enterprise Value
-11.67M
1-Year Change
-19.52%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.93M, a decrease of -47.45%. That is a compound annual growth rate of -4.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 8.90M | 21.92% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
| Jan 2, 2013 | 17.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.88B |
| Johnson & Johnson | 493.86B |
| AbbVie | 390.31B |
| UnitedHealth Group | 311.78B |
| AstraZeneca | 295.31B |
| Merck & Co. | 274.44B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |